Weight loss

Weight Loss

Indian Obesity Is Not Western Obesity: What the National Numbers Show

Dr. Himalay Agarwal

Dr. Himalay Agarwal

Consultant Internal Medicine

If you have read that roughly one in four Indian adults carries excess weight and it did not match what you see in your own family, the disagreement is real, and it is not about the population. It is about the tape.

India's largest health survey measured waists for the first time in its fifth round, and for women the answer it got was close to double the answer BMI gave for the same people. What follows is why the two measures diverge so far on an Indian body, who the burden is actually landing on, and where the curve is heading.

Key Takeaways:

  • NFHS-5 (2019-21) found 23% of women and 22.1% of men overweight by BMI, but 40% of women and 12% of men with abdominal obesity by waist. For women, the waist measure finds nearly double what BMI does.
  • The male 12% figure used the international 94 cm cut-off, not the Indian 90 cm threshold. It is a floor, not an estimate.
  • Asian Indian bodies carry more abdominal fat and less appendicular skeletal muscle than European bodies at the same BMI. A normal BMI is a weak reassurance here.
  • Undernutrition has not gone away. India is running both problems simultaneously, in different households and sometimes inside the same one.
  • By 2040, modelling projects overweight will more than double and obesity will triple among Indian adults aged 20 to 69. The largest relative increases are forecast in rural areas and at older ages.
  • India ranks second globally for children living with obesity, behind China, with roughly 41 million children aged 5 to 19 classified as overweight or obese in 2025.

What happened when India measured waists instead of weight

The National Family Health Survey of 2019 to 2021 was the first round to record waist circumference alongside height and weight. Published analysis of that dataset classified 23% of women and 22.1% of men as overweight on BMI. Measured at the waist, 40% of women and 12% of men met the criteria for abdominal obesity.

What NFHS-5 found when it measured both BMI and waist circumference:

  • Overweight on BMI: 23% of women and 22.1% of men.
  • Abdominal obesity on waist: 40% of women and 12% of men.
  • Abdominal obesity, ages 30 to 39: 49.3% of women. Age-band breakdown not reported for men.
  • Abdominal obesity, ages 40 to 49: 56.7% of women. Age-band breakdown not reported for men.

For women, the waist measure returns nearly twice the BMI figure. That gap is the argument in one line. The two instruments are not two views of the same thing, and on an Indian body the one that most headlines quote is the one that finds least.

The age pattern in women is steeper still, rising from 49.3% in the thirties to 56.7% in the forties. The survey interviewed women only up to 49, so what happens after that is not in this dataset, and the same age detail was not reported for men.

Two limits belong with these figures:

  • This is a single cross-sectional survey read at one moment, so it describes how common abdominal obesity is rather than how fast it is changing.
  • Waist readings shift with tape placement, posture, breathing and whether the person has just eaten, which is why the thresholds are treated as population risk markers rather than precise personal lines.

The men's figure is measured against the wrong line

There is a second reason the male number looks small. The analysis defined abdominal obesity as a waist above 80 cm in women and above 94 cm in men, which are the generic international cut-offs rather than the Indian ones. Indian consensus places the male threshold at 90 cm.

Every Indian man whose waist sits between 90 and 94 cm therefore falls outside the survey's count and inside the Indian one. That makes 12% a floor rather than an estimate, and how far the figure would move on Indian thresholds has not been published for this dataset.

Why the same BMI describes a different body here

Comparative body-composition work using DXA scans across European, Maori, Pacific Island and Asian Indian adults found Asian Indians carrying more total fat, more of it in the abdominal region, and the lowest appendicular skeletal muscle mass of the four groups, before and after adjusting for age, height and weight. At a BMI of 30, predicted body fat in that work was roughly 29% for European men against roughly 37% for Asian Indian men.

Two consequences follow.

The first: Fat that does not fit in the layer under the skin tends to end up around the organs instead, which is why visceral fat can be raised at a body size a Western chart calls unremarkable.

The second: Skeletal muscle is the body's largest site of insulin-stimulated glucose disposal, so a lower muscle reserve is one of several accounts offered for why insulin resistance appears earlier here. It is a plausible account rather than a settled one, and it sits alongside diet composition, early-life factors and genetics rather than replacing them.

The burden is not replacing undernutrition, it is arriving beside it

The Indian pattern is also unusual in who it reaches. In the same national analysis, more than half of adults with abdominal obesity fell in the top two wealth quintiles, at 51.8% of women and 63% of men. Prevalence was lowest in scheduled-tribe populations, at 24.4% of women and 6.1% of men, and higher in urban than rural residents.

Undernutrition and micronutrient deficiency have not gone anywhere in the meantime. India is running both problems at once, in different households and sometimes inside the same one, which is not the sequence high-income countries went through.

That matters for how the subject gets talked about. A country still managing shortfall does not automatically build the clinical habits, the screening pathways or the public language for excess, and the assumption that thinness is health survives longer than the data supports it.

Where the curve is going, and who it is going to

Forecasting work using multi-state life tables projects that among Indian adults aged 20 to 69, the prevalence of overweight will more than double and obesity will triple between 2010 and 2040. By 2040 the modelled figures reach:

  • 30.5% overweight and 9.5% obesity in men
  • 27.4% overweight and 13.9% obesity in women

The largest relative increases were forecast in rural areas and at older ages, which cuts against the assumption that this is a young, urban, metropolitan problem.

That forecast is a model rather than a measurement. It was built on earlier survey rounds and on assumptions about mortality and incidence, so it describes a trajectory the data pointed at, not an outcome anyone has observed. The direction is the durable part. The decimal places are not.

The paediatric picture is where India's position is starkest. As of 2026, the World Obesity Atlas ranks India second globally, behind China, for the number of children living with obesity, with roughly 41 million Indian children aged 5 to 19 classified as overweight or obese in 2025 and more than 56 million projected to be overweight by 2040.

What a population number can and cannot tell you about yourself

None of these figures describe an individual. A prevalence percentage tells you how common something is in a group. It does not tell you whether your own waist, blood sugar or liver is doing anything worth acting on.

The practical step is not to look up which side of a national average you fall on. It is to have a waist, a set of blood markers and a history read together by a registered medical practitioner, which is what a structured metabolic assessment is for.

A national figure tells you which questions are worth asking in this country. It cannot tell you which of them apply to you. That second answer only comes from measurements taken on your own body and read by someone qualified to interpret them.

A national number tells you which questions are worth asking. Only your own measurements tell you which apply to you. A Voy metabolic assessment reads your waist, your blood markers and your history together. Book an assessment.

This article is for general information and education only and is not medical advice, diagnosis, or treatment. GLP-1 and other medications referenced are prescription-only and are appropriate only for certain people under the supervision of a qualified clinician. Do not start, stop, or change any medication based on this article. Please consult a registered medical practitioner about your individual circumstances. Information reflects what was available at the time of review and may change.

Related articles

Premium Star Icon

Join 25 Lakh members getting healthy

Doctor-backed weight loss support you can trust

4.7 / 5 (28,937+ reviews)

Trusted by 25 Lakh +
Customers

Still confused?

App Store
Download on theApp Store
Google Play
Get it onGoogle Play